Company Description

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors.

Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity.

Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Genenta Science S.p.A.

Country	Italy
Founded	2014
IPO Date	Dec 15, 2021
Industry	Conglomerates
Sector	Industrials
Employees	9
CEO	Pierluigi Paracchi

Contact Details

Address: Via dell’Annunciata 31 Milan, Michigan 20121 Italy
Phone	39 02 29 00 10 55
Website	genenta.com

Stock Details

Ticker Symbol	GNTA
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	EUR
IPO Price	$11.50
CIK Code	1838716
CUSIP Number	36870W100
ISIN Number	US36870W1009
SIC Code	2836

Key Executives

Name	Position
Pierluigi Paracchi	Co-Founder, Chairman, Chief Executive Officer and GM
Dr. Luigi Naldini M.D., Ph.D.	Co-Founder and Chairman of Scientific Advisory Board
Dr. Bernard Rudolph Gentner M.D., Ph.D.	CO-Founder and Scientific Advisory Board Member
Richard B. Slansky	Principal Financial and Accounting Officer
Gianfranco De Nigris	Vice President Corporate Development
Dr. Stefania Mazzoleni Ph.D.	Director of Program Development
Barbara Regonini	Director of Finance

Latest SEC Filings

Date	Type	Title
Oct 2, 2026	SCHEDULE 13D/A	Filing
Sep 11, 2026	6-K	Report of foreign issuer
Sep 2, 2026	6-K	Report of foreign issuer
Jul 31, 2026	6-K	Report of foreign issuer
Jul 14, 2026	6-K	Report of foreign issuer
Jul 1, 2026	6-K	Report of foreign issuer
Jun 26, 2026	6-K	Report of foreign issuer
Jun 24, 2026	6-K	Report of foreign issuer
Jun 17, 2026	6-K	Report of foreign issuer
Jun 16, 2026	6-K	Report of foreign issuer

View All SEC Filings